β-catenin expression pattern in primary oral squamous cell carcinoma

Chinese Medical Journal

Volumn 121, Issue 19, 2008, Pages 1866-1870

  Cai, Zhi Gang ^a   Shi, Xiao Jian ^a   Gao, Yan ^a   Wei, Ming Jie ^a   Wang, Cun Yu ^b   Yu, Guang Yan ^a  

^a PEKING UNIVERSITY   (China)

^b UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Immunohistochemical staining; Squamous cell carcinoma; catenin

Indexed keywords

BETA CATENIN;

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CELL MEMBRANE; CELL NUCLEUS; CORRELATIONAL STUDY; CYTOPLASM; DISEASE ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION;

EID: 54349112686     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200810010-00003     Document Type: Article

References (24)

1. Smythe WR, Williams JP, Wheelock MJ, Johnson KR, Kaiser LR, Albelda SM. Cadherin and catenin expression in normal human bronchial epithelium and non-small cell lung cancer. Lung Cancer 1999; 24: 157-168.
2. Helliwell TR. Molecular markers of metastasis in squamous carcinomas. J Pathol 2001; 194: 289-293.
3. Shimada Y, Imamura M, Watanabe G, Uchida S, Harada H, Makino T, et al. Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer 1999; 80: 1281-1288.
4. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, et al. E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 1994; 54: 291-296.
5. Shibuya Y, Ri S, Umeda M, Yoshikawa T, Masago H, Komori T. Ultrastructural localization of E-cadherin and α/β-catenin in adenoid cystic carcinoma. Histopathology 1999; 35: 423-431.
6. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-1455.
7. Knudsen KA, Wheelock MJ. Plakoglobin or an 83 kD homotogue distinct from β-catenin, interacts with E-cadherin and N-cadherin. J Cell Biol 1992; 118: 671-679.
8. Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, et al. Beta-catenin expression in human cancers. Am J Pathol 1996; 148: 39-46.
9. Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suárez A, Armas A. β-catenin expression pattern in stage I and stage II ovarian carcinomas. Am J Pathol 1999; 155: 527-536.
10. Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WC, Kremers ED, Dinjens WN, et al. Reduad expression of the cadherin/catenin complex in oesophageal adenocarcinomas correlates with poor prognosis. J Pathol 1997; 182: 331-338.
11. Zhong LP, Li J, Zhang CP, Zhu HG, Sun J, Zhang ZY. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Arch Oral Bio 2007; 52: 740-747.
12. Murakami A, Nakagawa T, Fukushima C, Torii M, Sueoka K, Nawata S, et al. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis. Oncol Rep 2008; 19: 99-104.
13. Bánkfalvi A, Krassort M, Végh A, Felszeghy E, Piffkó J. Deranged expression of the E-cadherin/β-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med 2002; 31: 450-457.
14. Mahomed F, Altini M, Meer S. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Dis 2007; 13: 386-392.
15. Bánkfalvi A, Krassort M, Buchwalow IB, Végh A, Felszeghy E, Piffkó J. Gains and losses of adhesion molecules (CD44, E-cadherin, and β-catenin) during oral carcinogenesis and tumor progression. J Pathol 2002; 198: 343-351.
16. Zhao XJ, Li H, Chen H, Liu YX, Zhang LH, Liu SX, et al. Expression of E-cadherin and β-catenin in human esophageal squamos cell carcinoma: relationship with prognosis. World J Gastroenterol 2003; 9: 225-232.
17. Bremnes RM, Veve R, Hirsch FR, Franklin WA. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002; 36: 115-124.
18. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival. Gastroenterology 1997; 112: 46-54.
19. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Kosma VM. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Br J Cancer 1999; 80: 477-482.
20. Joo YE, Rew JS, Kim HS, Choi SH, Park CS, Kim SJ. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers. Digestion 2001; 64: 111-119.
21. Blankesteijn WM, van Gijn ME, Essers-Janssen YP, Daemen MJ, Smits JF. β-catenin, an inducer of uncontrolled cell proliferation and migration in malignancies, is localized in the cytoplasm of vascular endothelium during neovascularization after myocardial infarction. Am J Pathol 2000; 157: 877-883.
22. Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T. Expression of nuclear β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 2000; 156: 865-875.
23. Pirinen RT, Hirvikoski P, Johansson RT, Hollmén S, Kosma VM. Reduced expression of α-catenin, β-catenin, γ-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol (Chin) 2001; 54: 391-395.
24. Pukkila MJ, Virtaniemi JA, Kumpulainen EJ, Pirinen RT, Johansson RT, Valtonen HJ, et al. Nuclear β-catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma. J Clin Pathol 2001; 54: 42-47.